Research degree in "personalising medical therapy in Crohn's disease".
Interest in database research and review of clinical, endoscopic, radiologic and biochemical factors.
Further laboratory-based research in metabonomics at South Kensington.
- Supervision of two research students: BSc and MRes.
- Consultant Gastroenterologist
- Head of IBD Clinical Trials Unit
Tassone D, Singh S, Sheng Ding N, 2021, Editorial: impact of body mass index on clinical outcomes in patients with ulcerative colitis treated with tofacitinib, Alimentary Pharmacology & Therapeutics, Vol:54, ISSN:0269-2813, Pages:206-207
et al., 2021, Systematic review: efficacy of escalated maintenance anti-tumour necrosis factor therapy in Crohn's disease, Alimentary Pharmacology & Therapeutics, Vol:54, ISSN:0269-2813, Pages:249-266
et al., 2021, Low failure to attend rates and increased clinic capacity with Telehealth: A highly effective outpatient model that should continue beyond the COVID-19 pandemic, Journal of Gastroenterology and Hepatology, Vol:36, ISSN:0815-9319, Pages:1136-1137
et al., 2020, Long-term outcomes of perianal fistulizing Crohn's disease in the biologic era, Jgh Open, Vol:5, ISSN:2397-9070, Pages:235-241
et al., 2020, Higher anti-tumor necrosis factor-alpha drug levels are associated with improved radiological outcomes in patients with perianal fistulizing Crohn's disease: A retrospective multicenter study, WILEY, Pages:133-133, ISSN:0815-9319